X121.1 may be used to immunoprecipitate active CDK1 complexes.
| Inventor | Institute |
|---|---|
| Julian Gannon | Cancer Research UK, London Research Institute: Clare Hall Laboratories |
| Cat. #: | 151181 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cell biology;Genetics |
| Application: | WB ; IHC ; IP ; WB |
| Target: | Cyclin B2 |
| Reactivity: | Xenopus laevis |
| Clone: | X121.10 |
| Host: | Mouse |
| Class: | Monoclonal |
| Alternate name: | Cyclin B2; HsT17299 |
|---|---|
| Product description: | X121.1 may be used to immunoprecipitate active CDK1 complexes. |
| Conjugation: | Unconjugated |
| Isotype: | IgG1 |
| Immunogen: | Xenopus laevis Cyclin B2 |
| Myeloma used: | Sp2/0-Ag14 |
| Target background: | Cyclins bind to and regulate the activity of the Cyclin Dependent Protein Kinases (CDKs). |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 0.91 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Integrative module analysis of HCC gene expression landscapes Li et al. 2020. Exp Ther Med. 19(3):1779-1788. PMID: 32104233. Identification of the nuclear localization signal in Xenopus cyclin E and analysis of its role in replication and mitosis. Activation of Xenopus eggs by the kinase inhibitor 6-DMAP suggests a differential regulation of cyclin B and p39(mos) proteolysis. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151030 | Anti-Progesterone [11P14] |
Key Info
Anti-Progesterone [11P14]
|
View Tool | |||||||||||||||||||
| 151015 | Anti-CyclinA [E70.1] |
Key Info
Anti-CyclinA [E70.1]
|
View Tool | |||||||||||||||||||
| 151031 | Anti-RuvA [RuvA 12C6] |
Key Info
Anti-RuvA [RuvA 12C6]
|
View Tool | |||||||||||||||||||
| 151040 | Anti-CD11 & CD18 [24] |
Key Info
Anti-CD11 & CD18 [24]
|
View Tool | |||||||||||||||||||
| 151018 | Anti-Mos [R38.1] |
Key Info
Anti-Mos [R38.1]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.